Replies to post #2734 on Todos Med Ltd (TOMDF)

[giannerp]

I am an old $AMBS investor, since 2012. He did many mistakes on the financial side (toxic debts) and communication side. He pumped a lot the AMBS pipeline, very unusual behavior for a CEO. Even worst, no updates since too much time. For sure he didn't have the correct experience at that time.
That being said, I continued to follow him and I jumped in Todos as well. I agree with you. Your summary of the opportunities is right. I expect to see better moves in the future. It is also a matter of visibility, OTC doesn't help.
I know perfectly the risk we are running.

[leslunier]

Another old investor. Same MO. Dilution !!! Two 3.5 million convertable notes with 30 % discount with no restriction on converting. Wouldn't it be better to sell those shares on the open market and save the company the 30% discount?.

Anyone that thinks the note holders are not converting at these low prices are kidding themselves. So again dilution!

Provista acquisition with more dilution and toxic financing ? Yet to be seen at what cost. At least they are a revenue producing company. Question is does that support the cost??